Publicacións en colaboración con investigadores/as de Université Catholique de Louvain (23)

2023

  1. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  2. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

    Nature Medicine, Vol. 29, Núm. 11, pp. 2885-2901

2022

  1. Barriers to the Intestinal Absorption of Four Insulin-Loaded Arginine-Rich Nanoparticles in Human and Rat

    ACS Nano, Vol. 16, Núm. 9, pp. 14210-14229

2021

  1. A generic emergency protocol for patients with inborn errors of metabolism causing fasting intolerance: A retrospective, single-center study and the generation of www.emergencyprotocol.net

    Journal of Inherited Metabolic Disease, Vol. 44, Núm. 5, pp. 1124-1135

  2. A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 524-545

  3. Correction to: A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin (Drug Delivery and Translational Research, (2021), 11, 2, (524-545), 10.1007/s13346-021-00920-x)

    Drug Delivery and Translational Research

2020

  1. Intestinal NAPE-PLD contributes to short-term regulation of food intake via gut-to-brain axis

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 319, Núm. 3, pp. E647-E657

  2. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study

    European Archives of Oto-Rhino-Laryngology, Vol. 277, Núm. 8, pp. 2251-2261

  3. Toll-like receptor 3 increases antigen-presenting cell responses to a pro-apoptotic stimulus, yet does not contribute to systemic lupus erythematosus genetic susceptibility

    Clinical and Experimental Rheumatology, Vol. 38, Núm. 5, pp. 881-890

2018

  1. PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy

    Journal of Controlled Release, Vol. 276, pp. 125-139

  2. Prebiotics supplementation impact on the reinforcing and motivational aspect of feeding

    Frontiers in Endocrinology, Vol. 9, Núm. MAY

  3. Protamine nanocapsules as carriers for oral peptide delivery

    Journal of Controlled Release, Vol. 291, pp. 157-168

2017

  1. Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes

    Expert Opinion on Drug Delivery, Vol. 14, Núm. 1, pp. 23-36

  2. Solvent-free protamine nanocapsules as carriers for mucosal delivery of therapeutics

    European Polymer Journal, Vol. 93, pp. 695-705

2016

  1. A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease

    Colloids and Surfaces B: Biointerfaces, Vol. 143, pp. 327-335

  2. The interaction of protamine nanocapsules with the intestinal epithelium: A mechanistic approach

    Journal of Controlled Release, Vol. 243, pp. 109-120

2015

  1. Proton channels and exchangers in cancer

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1848, Núm. 10, pp. 2715-2726

2014

  1. Pneumococcal vaccination in Europe: Schedule adherence

    Clinical Therapeutics, Vol. 36, Núm. 5

2013

  1. Bandwidth selection for the estimation of transition probabilities in the location-scale progressive three-state model

    Computational Statistics, Vol. 28, Núm. 5, pp. 2185-2210

  2. Development of PLGA-mannosamine nanoparticles as oral protein carriers

    Biomacromolecules, Vol. 14, Núm. 11, pp. 4046-4052